Chemed Corporation (NYSE:CHE) Q2 2022 Earnings Conference Call July 28, 2022 10:00 AM ET Company Participants Holley Schmidt - Assistant Controller Kevin McNamara - President and Chief Executive Officer Dave Williams - Executive Vice President and Chief Financial Officer Nick Westfall - President and Chief Executive Officer of Chemed VITAS Healthcare Corporation Subsidiary Conference Call Participants Kevin Fischbeck - Bank of America Ben Hendrix - RBC Capital Markets Operator Good day and welcome to the Ch ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x Quarterly Report Under Section 13 or 15 (d) of the Securities Exchange Act of 1934 For the Quarterly Period Ended June 30, 2022 o Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Commission File Number: 1-8351 CHEMED CORPORATION (Exact name of registrant as specified in its charter) Delaware 31-0791746 (State or other jurisdiction of incorporation or organization) (IRS Emplo ...

| --- | --- | |----------|---------------------------| | | | | Employer | Identification No.) 45202 | UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x Quarterly Report Under Section 13 or 15 (d) of the Securities Exchange Act of 1934 For the Quarterly Period Ended March 31, 2022 o Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Commission File Number: 1-8351 CHEMED CORPORATION (Exact name of registrant as specified in its ...

Chemed Corporation (NYSE:CHE) Q1 2022 Earnings Conference Call April 27, 2022 10:00 AM ET Company Participants Kevin McNamara – President and Chief Executive Officer Nick Westfall – President and Chief Executive Officer of Chemed VITAS Healthcare Corporation Subsidiary Dave Williams – Executive Vice President and Chief Financial Officer Holley Schmidt – Assistant Controller Conference Call Participants Joanna Gajuk – Bank of America Ben Hendrix – RBC Capital Markets Operator Good day and thank you for stand ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K þ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 ¨ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Transition Period from ________ to________ Commission File Number: 1-8351 CHEMED CORPORATION (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporati ...

Chemed Corporation (NYSE:CHE) Q4 2021 Earnings Conference Call February 25, 2022 10:00 AM ET Company Participants Kevin McNamara - President and CEO Dave Williams - EVP and CFO Nick Westfall - President and Chief Executive Officer-Chemed's VITAS Healthcare Corporation Subsidiary Conference Call Participants Joanna Gajuk - Bank of America Benjamin Hendrix - RBC Capital Markets Operator Thank you for standing by, and welcome to the Chemed Corporation Fourth Quarter 2021 Earnings Conference Call. [Operator Ins ...

45202 (Zipcode) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x Quarterly Report Under Section 13 or 15 (d) of the Securities Exchange Act of 1934 For the Quarterly Period Ended September 30, 2021 o Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Commission File Number: 1-8351 CHEMED CORPORATION (Exact name of registrant as specified in its charter) Delaware 31-0791746 (State or other jurisdiction of incorporation or org ...

Chemed Corporation (NYSE:CHE) Q3 2021 Earnings Conference Call October 29, 2021 10:00 AM ET Company Participants Sherri Warner - IR Kevin McNamara - President and CEO Dave Williams - EVP and CFO Nick Westfall - President and CEO-Chemed's VITAS Healthcare Corporation Subsidiary Conference Call Participants Joanna Gajuk - Bank of America Frank Morgan - RBC Capital Operator Good day, ladies and gentlemen. Thank you for standing by and welcome to Chemed Corporation Third Quarter 2021 Earnings Conference Call. A ...

| --- | --- | |-------|------------------------------| | | | | (IRS | Employer Identification No.) | | | 45202 (Zip code) | UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x Quarterly Report Under Section 13 or 15 (d) of the Securities Exchange Act of 1934 For the Quarterly Period Ended June 30, 2021 o Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Commission File Number: 1-8351 CHEMED CORPORATION (Exact name of registran ...

Chemed Corporation (NYSE:CHE) Q2 2021 Earnings Conference Call July 28, 2021 10:00 AM ET Company Participants Sherri Warner - Investor Relations Kevin McNamara - President & Chief Executive Officer Dave Williams - Executive Vice President & Chief Financial Officer Nick Westfall - President and Chief Executive Officer-Chemed's VITAS Healthcare Corporation subsidiary Conference Call Participants Frank Morgan - RBC Capital Markets Joanna Gajuk - Bank of America Operator Good day, and thank you for standing by. ...